Sprache NL EN DE ES FR UK IT

Neubauanalyse

Kartellanalyse

Saubere Grundlage für MEP-, Dokument- und thematische Netzwerkanalyse. Keine harten politischen Labels, sondern überprüfbare Evidenz.

You are here

ONTWERPRESOLUTIE over de gedelegeerde verordening van de Commissie van 14 maart 2024 tot wijziging van Gedelegeerde Verordening (EU) 2016/1675 wat betreft de toevoeging van Kenia en Namibië aan de tabel in punt I van de bijlage en de schrapping van Barbados, Gibraltar, Panama, Uganda en de Verenigde Arabische Emiraten uit die tabel

You are viewing a dossier. From here you can see which actors, signals and linked vote events are visible around this document.

Jump to

Dossier Actors Sources and context Supporting layers Linked vote events

Dossier

ONTWERPRESOLUTIE over de gedelegeerde verordening van de Commissie van 14 maart 2024 tot wijziging van Gedelegeerde Verordening (EU) 2016/1675 wat betreft de toevoeging van Kenia en Namibië aan de tabel in punt I van de bijlage en de schrapping van Barbados, Gibraltar, Panama, Uganda en de Verenigde Arabische Emiraten uit die tabel

Ontwerpresolutie | 2024-04-17 | source: plenary_documents

Open bronpagina Leesbare metadata Wikipedia zoeken

18Actors

0Signals

9EP term

Actors

Damien Carême

Role: co-author

Method: name-normalized | confidence 0.7500

Dragoş Pîslaru

Role: co-author

Method: name-normalized | confidence 0.7500

Eero Heinäluoma

Role: co-author

Method: name-normalized | confidence 0.7500

Eva-Maria Alexandrova Poptcheva

Role: co-author

Method: name-normalized | confidence 0.7500

Evelyn Regner

Role: co-author

Method: name-normalized | confidence 0.7500

Franco Roberti

Role: co-author

Method: name-normalized | confidence 0.7500

Isabel Benjumea Benjumea

Role: co-author

Method: name-normalized | confidence 0.7500

Javier Zarzalejos

Role: co-author

Method: name-normalized | confidence 0.7500

José Manuel García-Margallo y Marfil

Role: co-author

Method: name-normalized | confidence 0.7500

Kira Marie Peter-Hansen

Role: co-author

Method: name-normalized | confidence 0.7500

Luděk Niedermayer

Role: co-author

Method: name-normalized | confidence 0.7500

Manon Aubry

Role: co-author

Method: name-normalized | confidence 0.7500

Martin Schirdewan

Role: co-author

Method: name-normalized | confidence 0.7500

Paul Tang

Role: co-author

Method: name-normalized | confidence 0.7500

Pedro Marques

Role: co-author

Method: name-normalized | confidence 0.7500

Ramona Strugariu

Role: co-author

Method: name-normalized | confidence 0.7500

Rasmus Andresen

Role: co-author

Method: name-normalized | confidence 0.7500

Roberts Zīle

Role: co-author

Method: name-normalized | confidence 0.7500

Sources and context Source text and aggregated content + Provenance and audit

Source text and aggregated content

ONTWERPRESOLUTIE over de gedelegeerde verordening van de Commissie van 14 maart 2024 tot wijziging van Gedelegeerde Verordening (EU) 2016/1675 wat betreft de toevoeging van Kenia en Namibië aan de tabel in punt I van de bijlage en de schrapping van Barbados, Gibraltar, Panama, Uganda en de Verenigde Arabische Emiraten uit die tabel

Provenance and audit

This block makes visible which source layer and datapoints the current view is based on.

Source layer plenary_documents

Canonical identifier B-9-2024-0222

Official source URL https://data.europarl.europa.eu/eli/dl/doc/B-9-2024-0222

Title and language layer Only Dutch title available

EP term 9

News context around this event

Use these links to quickly search reputable news sources around the event date using the title and keywords.

Search period: 2024-04-17

Keywords: ONTWERPRESOLUTIE over de gedelegeerde verordening van de Commissie van 14 maart 2024 tot wijziging van Gedelegeerde Ver…

Reuters Financial Times Politico Europe The Guardian NRC de Volkskrant Google News

Supporting layers Signals

Signals

No signal clusters found for this topic yet.

Linked vote events Votes and seat distribution

Linked vote events

No official vote items linked to this dossier yet.

Next logical step

Use these routes to continue your research from this page.

Continue to topics Continue to evidence board Back to dashboard